A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT02521870 · TERMINATED
Trial details
- NCT number
- NCT02521870
- Sponsor
- Dynavax Technologies Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2020-04-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.